Skip to main content
NIH funding notice PAR-19-040

Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)

Closed on September 14, 2021.

Posted
October 26, 2018
Close date
September 14, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,407,289 in first-year total cost, median $741,757.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 MDCN-B (50)]6
  2. Special Emphasis Panel[ZRG1 DKUS-P (50)]4

Most frequent institutions

  1. UNIVERSITY OF ALABAMA AT BIRMINGHAM2
  2. HENRY M. JACKSON FDN FOR THE ADV MIL/MED1
  3. IOWA STATE UNIVERSITY1
  4. MISSISSIPPI STATE UNIVERSITY1
  5. OHIO STATE UNIVERSITY1
Competing awards under PAR-19-040 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022First Aid Medicine to Treat Vesicant Induced Corneal Injury1U01EY032973-01A1CHANDLER, HEATHERMA, JIANJIEZHU, HUAOHIO STATE UNIVERSITY, OH$780,450ZRG1
2022Antiglutamatergic Therapy to Protect the Brain Against Nerve Agents1U01NS123252-01A1BRAGA, MARIA F.HENRY M. JACKSON FDN FOR THE ADV MIL/MED, MD$762,477ZRG1
2022Novel lead compound advancement for mitigating halogen-induced mortality and morbidity.1U01ES033263-01A1AHMAD, SHAMAUNIVERSITY OF ALABAMA AT BIRMINGHAM, AL$742,499ZRG1
2022Optimization of Bile Sequestrants to Treat Superwarfarin Poisoning1U01NS127746-01FEINSTEIN, DOUGLAS L.UNIVERSITY OF ILLINOIS AT CHICAGO, IL$673,844ZRG1
2021Saracatinib and 1400W Counteract Nerve Agents-induced Long-term Neurotoxicity1U01NS117284-01A1THIPPESWAMY, THIMMASETTAPPAIOWA STATE UNIVERSITY, IA$727,305ZRG1
2021Optimization of Substituted Phenoxyalkyl Pyridinium Oximes as Therapies for Organophosphate Poisoning1U01NS123255-01CHAMBERS, JANICE ELAINEMISSISSIPPI STATE UNIVERSITY, MS$706,875ZRG1
2020Antibody-based countermeasures against fentanyl and its analogues1U01DA051658-01PRAVETONI, MARCOUNIVERSITY OF MINNESOTA, MN$813,791ZRG1
2020Novel pediatric anticonvulsants for nerve agents1U01NS117209-01REDDY, DOODIPALA SAMBATEXAS A&M UNIVERSITY HEALTH SCIENCE CTR, TX$755,985ZRG1
2020Optimization of Novel Molecular Target-based Drugs for Arsenical Skin Injury1U01AR078544-01ATHAR, MOHAMMADUNIVERSITY OF ALABAMA AT BIRMINGHAM, AL$741,015ZRG1
2020Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur Mustard1U01EY031650-01MOHAN, RAJIV RAVINDRAUNIVERSITY OF MISSOURI-COLUMBIA, MO$703,048ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.